Turnaround in FY/2021: Significant sales growth (+30%) and substantially improved EBIDTA (+84%) - cl
DGAP-News: aap Implantate AG / Key word(s): Annual Results/Annual Report31.03.2022 / 07:20 The issuer is solely responsible for the content of this announcement. - Sales: EUR 12.2 million (+30% yoy) - CER[1]: +32% yoy; all markets with significant double-digit growth rates- EBITDA: EUR -0.8 million (+84% yoy);...